Fibrinogen Aalpha312 and Bbeta448 polymorphisms are not related to bleeding during oral vitamin K-antagonist treatment

Thromb Haemost. 2007 Apr;97(4):676-8.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acenocoumarol / adverse effects
  • Administration, Oral
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects*
  • Case-Control Studies
  • Fibrinogen / genetics*
  • Genotype
  • Hemorrhage / chemically induced*
  • Hemorrhage / genetics
  • Humans
  • Netherlands
  • Odds Ratio
  • Phenprocoumon / adverse effects
  • Polymorphism, Single Nucleotide*
  • Risk Assessment
  • Risk Factors
  • Vitamin K / antagonists & inhibitors*

Substances

  • Anticoagulants
  • BBeta fibrinogen
  • fibrinogen Aalpha
  • Vitamin K
  • Fibrinogen
  • Acenocoumarol
  • Phenprocoumon